A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.
Daniel Winn, MD
Advertisement
Articles by Daniel Winn, MD
Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.
Advertisement
Latest Updated Articles
- CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results
Published: November 8th 2019 | Updated:
- Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:
- Physician Behavior Impact When Revenue Shifted From Drugs to Services
Published: April 21st 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
3
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
4
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
5
